Literature DB >> 24002955

First report on the validity of a continuous Metabolic syndrome score as an indicator for Metabolic syndrome in a national sample of paediatric population - the CASPIAN-III study.

Gita Shafiee1, Roya Kelishadi, Ramin Heshmat, Mostafa Qorbani, Mohammad Esmaeil Motlagh, Tahereh Aminaee, Gelayol Ardalan, Mahnaz Taslimi, Parinaz Poursafa, Bagher Larijani.   

Abstract

INTRODUCTION: The aim of this study was to assess the validity of a continuous Metabolic Syndrome score (cMetS) in a nationally representativesample of Iranian children and to identify sex and age-specific optimal cut-off points of cMetS that are associated with MetS.
MATERIAL AND METHODS: This study was conducted among 3,254 schoolchildren aged 10-18 years. cMetS was derived by aggregating ageand sex-standardised residuals of waist circumference (WC), mean arterial pressure (MAP), glucose, high density lipoprotein-cholesterol(HDL-C) and triglycerides (TG). To determine the optimal cut-off points of cMetS for predicting MetS, receiver operator characteristic(ROC) curve analysis was used with an estimation of the variables' sensitivity and specificity.
RESULTS: A graded relationship was documented between cMetS and the number of risk factors. Increasing mean values of cMetS with increasingnumbers of components were apparent for both genders. The overall optimal cMetS cut-off point for predicting the presence of MetS was 2.93 [sensitivity= 92%, specificity = 91%, area of the curve = 0.96 (0.95-0.97)]. The values for boys and girls were 2.97 and 3.26 respectively in the total study.
CONCLUSION: This nationwide study confirmed the validity of the cMetS score in a population-based sample of Iranian children. cMetSappears to be an appropriate index for investigating the association between potential risk factors and MetS in epidemiological researchin Iran.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24002955     DOI: 10.5603/ep.2013.0006

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  13 in total

1.  Association of anthropometric indices with continuous metabolic syndrome in children and adolescents: the CASPIAN-V study.

Authors:  Hanieh-Sadat Ejtahed; Mostafa Qorbani; Mohammad Esmaeil Motlagh; Pooneh Angoorani; Shirin Hasani-Ranjbar; Hasan Ziaodini; Majzoubeh Taheri; Zeinab Ahadi; Shaghayegh Beshtar; Tahereh Aminaee; Ramin Heshmat; Roya Kelishadi
Journal:  Eat Weight Disord       Date:  2017-11-01       Impact factor: 4.652

2.  Development and Validation of a Simple Risk Model for Predicting Metabolic Syndrome (MetS) in Midlife: A Cohort Study.

Authors:  Musa S Ibrahim; Dong Pang; Gurch Randhawa; Yannis Pappas
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-06       Impact factor: 3.168

3.  A comparison between body mass index and waist circumference for identifying continuous metabolic syndrome risk score components in Iranian school-aged children using a structural equation modeling approach: the CASPIAN-V study.

Authors:  Hanieh-Sadat Ejtahed; Zohreh Mahmoodi; Mostafa Qorbani; Pooneh Angoorani; Mohammad Esmaeil Motlagh; Shirin Hasani-Ranjbar; Hasan Ziaodini; Majzoubeh Taheri; Ramin Heshmat; Roya Kelishadi
Journal:  Eat Weight Disord       Date:  2020-08-09       Impact factor: 4.652

4.  An overview on the successes, challenges and future perspective of a national school-based surveillance program: the CASPIAN study.

Authors:  Zeinab Ahadi; Gita Shafiee; Mostafa Qorbani; Sima Sajedinejad; Roya Kelishadi; Seyed Masoud Arzaghi; Bagher Larijani; Ramin Heshmat
Journal:  J Diabetes Metab Disord       Date:  2014-12-20

5.  Associations between Sugar Intake from Different Food Sources and Adiposity or Cardio-Metabolic Risk in Childhood and Adolescence: The Korean Child-Adolescent Cohort Study.

Authors:  Yang-Im Hur; Hyesook Park; Jae-Heon Kang; Hye-Ah Lee; Hong Ji Song; Hae-Jeung Lee; Ok-Hyun Kim
Journal:  Nutrients       Date:  2015-12-31       Impact factor: 5.717

6.  Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.

Authors:  Cyntia B Manzano-Salgado; Maribel Casas; Maria-Jose Lopez-Espinosa; Ferran Ballester; Carmen Iñiguez; David Martinez; Dora Romaguera; Silvia Fernández-Barrés; Loreto Santa-Marina; Mikel Basterretxea; Thomas Schettgen; Damaskini Valvi; Jesus Vioque; Jordi Sunyer; Martine Vrijheid
Journal:  Environ Health Perspect       Date:  2017-09-20       Impact factor: 9.031

7.  Validity of continuous metabolic syndrome score for predicting metabolic syndrome; a systematic review and meta-analysis.

Authors:  Maryam Khazdouz; Motahareh Hasani; Sanaz Mehranfar; Hanieh-Sadat Ejtahed; Shirin Djalalinia; Armita Mahdavi Gorabi; Mohammad Esmaeili-Abdar; Shahrokh Karbalahi Saleh; Seyed Masoud Arzaghi; Hoda Zahedi; Amir Kasaeian; Mostafa Qorbani
Journal:  J Diabetes Metab Disord       Date:  2021-04-08

8.  Is the association of continuous metabolic syndrome risk score with body mass index independent of physical activity? The CASPIAN-III study.

Authors:  Ramin Heshmat; Gita Shafiee; Roya Kelishadi; Amir Eslami Shahr Babaki; Mohammad Esmaeil Motlagh; Tahereh Arefirad; Gelayol Ardalan; Asal Ataie-Jafari; Hamid Asayesh; Rasool Mohammadi; Mostafa Qorbani
Journal:  Nutr Res Pract       Date:  2015-07-27       Impact factor: 1.926

9.  Metabolic syndrome severity score: range and associations with cardiovascular risk factors.

Authors:  Borislav D Dimitrov; Karamfil M Bahchevanov; Penka A Atanassova; Mitko D Mitkov; Radka I Massaldjieva; Kostadin A Chompalov; Georgi K Hadzhipetrov
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-09-06

10.  Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: the CASPIAN-V study.

Authors:  Mostafa Qorbani; Roya Kelishadi; Ramin Heshmat; Motahar Heidari; Hanieh-Sadat Ejtahed; Mohammad Esmaeil Motlagh; Armita Mahdavi-Gorab; Hasan Ziaodini; Majzoubeh Taheri; Gita Shafiee; Shaghayegh Beshtar
Journal:  Diabetol Metab Syndr       Date:  2017-11-09       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.